SWOG clinical trial number
SWOG-8522

Treatment of Acute Non-Lymphocytic Leukemia Patients Over 50 Years

Closed
Phase
Published
Abbreviated Title
Treatment of Acute Non-Lymphocytic Leukemia Patients Over 50 Years
Activated
02/17/1986
Closed
11/01/1987

Publication Information Expand/Collapse

2010

The effect of complete remission (CR) and CR with incomplete platelet recovery (CRp) on outcome in acute myeloid leukemia: a combined eastern cooperative oncology group (ECOG), Southwest Oncology Group (SWOG), and M.D. Anderson Cancer Center study

Journal of Clinical Oncology 28(10):1766-1771;

1995

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

D Head;KJ Kopecky;J Weick;JC Files;D Ryan;K Foucar;M Montiel;J Bickers;A Fishleder;M Miller;C Spier;C Hanson;M Bitter;R Braziel;G Mills;J Welborn;W Williams;J Hewlett;C Willman;FR Appelbaum Blood 86(5):1717-1728

1994

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S38-S41

Reply to comments by Fenaux and Warrell.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S62

1992

Analysis of treatment failure in acute non-lymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study.

DH Ryan;KJ Kopecky;D Head;MR Grever;SM Shlaer;DA Lipschitz;HE Hynes;RH Vial;RW Veith;CH Gumbart AJCO 15(1):69-75

Background dysplasia in acute myeloblastic leukemia (AML).

D Head;K Kopecky;G Snow;FR Appelbaum;CL Willman U.S. Canadian Academy of Pathology Lab Investment 66:79A

1991

Survival with cytotoxic therapy in acute promyelocytic leukemia. A Southwest Oncology Group report.

DR Head;K Kopecky;J Hewlett;J Weick;D Ryan;J Files;J Bickers;K Foucar;M Montiel;A Fishleder;J Welborn;G Mills;E Billeter;C Willman;F Appelbaum Blood 78:268a

1989

Analysis of treatment failure in acute non-lymphocytic leukemia(ANLL) patients over fifty years of age: A Southwest Oncology Group(SWOG) study.

D Ryan;M Grever;K Kopecky ASCO 8:206(#800)

1987

Phase II evaluation of teniposide and ifosfamide in refractoryadult acute lymphocytic leukemia: A Southwest Oncology Group study.

DH Ryan;KJ Kopecky;D Head;CN Gumbart;MR Grever;C Karanes;JK Weick;C Coltman, Jr Cancer Treat Rep 71(7-8):713-716